The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parmely, M. J.
Right arrow Articles by Morrison, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parmely, M. J.
Right arrow Articles by Morrison, D. C.

The Journal of Immunology, Vol 151, Issue 1 389-396, Copyright © 1993 by American Association of Immunologists

ARTICLES

Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge

MJ Parmely, WW Zhou, CK Edwards 3d, DR Borcherding, R Silverstein and DC Morrison
Department of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City 66160-7420.

Adenosine (ADO) and its structurally related analogues are known to regulate the activities of immune and inflammatory cells, including a number of key functions of mononuclear phagocytes. In this study ADO and the synthetic ADO analogue MDL201112 inhibited TNF-alpha, but not IL-1, production by activated mouse peritoneal macrophages and the macrophage-like cell lines J774 and RAW-264. Northern blot analysis indicated that MDL201112 selectively inhibited the expression of steady- state TNF-alpha RNA in LPS+IFN-gamma-activated J774 and RAW-264 cells. This effect could not be attributed to changes in TNF-alpha RNA stability. In contrast, ADO had no effect on RNA levels for TNF-alpha and IL-1, suggesting that ADO acts at a post-transcriptional biosynthetic step. To determine whether either compound inhibited TNF- alpha-mediated inflammatory responses, mice were treated with ADO or MDL201112 and challenged with a lethal dose of endotoxic LPS and D- galactosamine, an hepatotoxin that sensitizes mice to lethal LPS challenge. A single i.p. injection of MDL201112 (100 mg/kg) protected over 90% of the mice, whether injected 1 h before or at the time of LPS challenge. MDL201112 also inhibited the appearance of TNF-alpha in the serum of LPS-challenged animals. The compound did not block D- galactosamine sensitization nor did it prevent lethality caused by the injection of rTNF-alpha. ADO failed to protect animals against endotoxin lethality, most likely due to the rapid metabolism of the nucleoside in vivo. These results establish ADO and MDL201112 as potent inhibitors of TNF-alpha biosynthesis and suggest that MDL201112 or similar analogues warrant further study as potential agents for the treatment of endotoxin shock and other diseases in which TNF-alpha plays an important pathogenic role.


This article has been cited by other articles:


Home page
 J BiochemHome page
K. Asamitsu, T. Yamaguchi, K. Nakata, Y. Hibi, A.-F. B. Victoriano, K. Imai, K. Onozaki, Y. Kitade, and T. Okamoto
Inhibition of Human Immunodeficiency Virus Type 1 Replication by Blocking I{kappa}B Kinase with Noraristeromycin
J. Biochem., November 1, 2008; 144(5): 581 - 589.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, S. V. Novitskiy, M. R. Blackburn, I. Biaggioni, and I. Feoktistov
Effect of A2B Adenosine Receptor Gene Ablation on Adenosine-Dependent Regulation of Proinflammatory Cytokines
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 694 - 700.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. T. Lee, M. Kim, J. D. Joo, G. Gallos, J.-F. Chen, and C. W. Emala
A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R959 - R969.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. H. Nemeth, C. S. Lutz, B. Csoka, E. A. Deitch, S. J. Leibovich, W. C. Gause, M. Tone, P. Pacher, E. S. Vizi, and G. Hasko
Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism
J. Immunol., December 15, 2005; 175(12): 8260 - 8270.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
G. Gallos, T. D. Ruyle, C. W. Emala, and H. T. Lee
A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F369 - F376.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Asanuma, T. Minamino, S. Sanada, S. Takashima, H. Ogita, A. Ogai, M. Asakura, Y. Liao, Y. Asano, Y. Shintani, et al.
{beta}-Adrenoceptor Blocker Carvedilol Provides Cardioprotection via an Adenosine-Dependent Mechanism in Ischemic Canine Hearts
Circulation, June 8, 2004; 109(22): 2773 - 2779.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
R. Silverstein
Review: D-Galactosamine lethality model: scope and limitations
Innate Immunity, June 1, 2004; 10(3): 147 - 162.
[Abstract] [PDF]

Home page
 J. Leukoc. Biol.Home page
G. W. Sullivan, D. D. Lee, W. G. Ross, J. A. DiVietro, C. M. Lappas, M. B. Lawrence, and J. Linden
Activation of A2A adenosine receptors inhibits expression of {alpha}4/{beta}1 integrin (very late antigen-4) on stimulated human neutrophils
J. Leukoc. Biol., January 1, 2004; 75(1): 127 - 134.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Gomez and M. V. Sitkovsky
Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo
Blood, December 15, 2003; 102(13): 4472 - 4478.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J F Kinsel and M V Sitkovsky
Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands
Ann Rheum Dis, November 1, 2003; 62(90002): ii22 - 24.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. Bshesh, B. Zhao, D. Spight, I. Biaggioni, I. Feokistov, A. Denenberg, H. R. Wong, and T. P. Shanley
The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells
J. Leukoc. Biol., November 1, 2002; 72(5): 1027 - 1036.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
E. Nemoto, H. Tada, and H. Shimauchi
Disruption of CD40/CD40 ligand interaction with cleavage of CD40 on human gingival fibroblasts by human leukocyte elastase resulting in down-regulation of chemokine production
J. Leukoc. Biol., September 1, 2002; 72(3): 538 - 545.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. S. Cohen, W. R. Law, C. R. Easington, K. Q. Cruz, B. A. Nardulli, R. A. Balk, J. E. Parrillo, and S. M. Hollenberg
Adenosine Deaminase Inhibition Attenuates Microvascular Dysfunction and Improves Survival in Sepsis
Am. J. Respir. Crit. Care Med., July 1, 2002; 166(1): 16 - 20.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Adanin, I. V. Yalovetskiy, B. A. Nardulli, A. D. Sam II, Z. S. Jonjev, and W. R. Law
Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1324 - R1332.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
F. Curreli, F. Cerimele, S. Muralidhar, L. J. Rosenthal, E. Cesarman, A. E. Friedman-Kien, and O. Flore
Transcriptional Downregulation of ORF50/Rta by Methotrexate Inhibits the Switch of Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 from Latency to Lytic Replication
J. Virol., April 16, 2002; 76(10): 5208 - 5219.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. Noji, M. Takayama, M. Mizutani, Y. Okamura, H. Takai, A. Karasawa, and H. Kusaka
KF24345, an Adenosine Uptake Inhibitor, Suppresses Lipopolysaccharide-Induced Tumor Necrosis Factor-alpha Production and Leukopenia via Endogenous Adenosine in Mice
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 200 - 205.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. Murakami, T. Hashikawa, T. Saho, M. Takedachi, T. Nozaki, Y. Shimabukuro, and H. Okada
Adenosine regulates the IL-1{beta}-induced cellular functions of human gingival fibroblasts
Int. Immunol., December 1, 2001; 13(12): 1533 - 1540.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
G. HASKÓ, D. G. KUHEL, J.-F. CHEN, M. A. SCHWARZSCHILD, E. A. DEITCH, J. G. MABLEY, A. MARTON, and C. SZABÓ
Adenosine inhibits IL-12 and TNF-{alpha} production via adenosine A2a receptor-dependent and independent mechanisms
FASEB J, October 1, 2000; 14(13): 2065 - 2074.
[Abstract] [Full Text]

Home page
 J. Leukoc. Biol.Home page
A. Eigler, V. Matschke, G. Hartmann, S. Erhardt, D. Boyle, G. S. Firestein, and S. Endres
Suppression of TNF-{alpha} production in human mononuclear cells by an adenosine kinase inhibitor
J. Leukoc. Biol., July 1, 2000; 68(1): 97 - 103.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. FLAMAND, S. BOUDREAULT, S. PICARD, M. AUSTIN, M. E. SURETTE, H. PLANTE, E. KRUMP, M.-J. VALLEE, C. GILBERT, P. NACCACHE, et al.
Adenosine, a Potent Natural Suppressor of Arachidonic Acid Release and Leukotriene Biosynthesis in Human Neutrophils
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S88 - 94.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Hasko, D. G. Kuhel, Z. H. Nemeth, J. G. Mabley, R. F. Stachlewitz, L. Virag, Z. Lohinai, G. J. Southan, A. L. Salzman, and C. Szabo
Inosine Inhibits Inflammatory Cytokine Production by a Posttranscriptional Mechanism and Protects Against Endotoxin-Induced Shock
J. Immunol., January 15, 2000; 164(2): 1013 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
T. Pedron, R. Girard, and R. Chaby
Exogenous Cyclic AMP, Cholera Toxin, and Endotoxin Induce Expression of the Lipopolysaccharide Receptor CD14 in Murine Bone Marrow Cells: Role of Purinoreceptors
Clin. Vaccine Immunol., November 1, 1999; 6(6): 885 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
N. Hirohashi, M.-G. Lei, and D. C. Morrison
LPS pretreatment of mouse peritoneal macrophages differentially modulates TNF{alpha} and iNOS expression
Innate Immunity, October 1, 1999; 5(5-6): 251 - 260.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Aldred and L. E. Nagy
Ethanol dissociates hormone-stimulated cAMP production from inhibition of TNF-alpha production in rat Kupffer cells
Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G98 - G106.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
C. C. Solorzano, A. Kaibara, P. J. Hess, P. D. Edwards, R. Ksontini, A. Abouhamze, S. McDaniel, J. Frazier, D. Trujillo, G. Kieft, et al.
Pharmacokinetics, immunogenicity, and efficacy of dimeric TNFR binding proteins in healthy and bacteremic baboon
J Appl Physiol, April 1, 1998; 84(4): 1119 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. R. Meldrum
Tumor necrosis factor in the heart
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R577 - R595.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. R. Wagner, C. McTiernan, V. J. Sanders, and A. M. Feldman
Adenosine Inhibits Lipopolysaccharide-Induced Secretion of Tumor Necrosis Factor-{alpha} in the Failing Human Heart
Circulation, February 17, 1998; 97(6): 521 - 524.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
D. R. Wagner, A. Combes, C. McTiernan, V. J. Sanders, B. Lemster, and A. M. Feldman
Adenosine Inhibits Lipopolysaccharide-Induced Cardiac Expression of Tumor Necrosis Factor-{alpha}
Circ. Res., January 23, 1998; 82(1): 47 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Bauer, M. G. Bouma, I. Herrmann, F. A. J. M. Van Den Wildenberg, G. S. Firestein, I. Marzi, and W. A. Buurman
Adenosine kinase inhibitor GP515 attenuates hepatic leukocyte adhesion after hemorrhagic hypotension
Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1297 - G1303.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. C. Montesinos, P. Gadangi, M. Longaker, J. Sung, J. Levine, D. Nilsen, J. Reibman, M. Li, C.-K. Jiang, R. Hirschhorn, et al.
Wound Healing Is Accelerated by Agonists of Adenosine A2 (Galpha s-linked) Receptors
J. Exp. Med., November 3, 1997; 186(9): 1615 - 1620.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Funaya, M. Kitakaze, K. Node, T. Minamino, K. Komamura, and M. Hori
Plasma Adenosine Levels Increase in Patients With Chronic Heart Failure
Circulation, March 18, 1997; 95(6): 1363 - 1365.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
L. C. Denlinger, P. L. Fisette, K. A. Garis, G. Kwon, A. Vazquez-Torres, A. D. Simon, B. Nguyen, R. A. Proctor, P. J. Bertics, and J. A. Corbett
Regulation of Inducible Nitric Oxide Synthase Expression by Macrophage Purinoreceptors and Calcium
J. Biol. Chem., January 5, 1996; 271(1): 337 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
M.J. Parmely, S.-Y. Hao, D.C. Morrison, and J.L. Pace
Role of macrophage-derived nitric oxide in endotoxin lethality in mice
Innate Immunity, February 1, 1995; 2(1): 45 - 52.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.